| Income Statement |
| Total Revenue | 51.60M |
|
| Revenues (USD) | 51.60M |
| Cost of Revenue | 40.28M |
| Gross Profit | 11.32M |
| Operating Expenses | 132.48M |
| Research and Development Expense | 47.26M |
| Selling, General and Administrative Expense | 74.39M |
| Operating Income | -121.16M |
| Income Tax Expense | 111.00K |
| Net Income | -115.57M |
| Net Income Common Stock | -115.57M |
| Net Income Common Stock (USD) | -115.57M |
| Consolidated Income | -115.57M |
| Earnings per Basic Share | -0.79 |
| Earnings per Basic Share (USD) | -0.79 |
| Earnings per Diluted Share | -0.79 |
| Earning Before Interest & Taxes (EBIT) | -115.46M |
| Earning Before Interest & Taxes (USD) | -115.46M |
| Weighted Average Shares | 146.04M |
| Weighted Average Shares Diluted | 146.04M |
| Balance Sheet |
| Cash and Equivalents | 66.20M |
| Cash and Equivalents (USD) | 66.20M |
| Investments | 509.25M |
| Investments Current | 509.25M |
| Trade and Non-Trade Receivables | 100.55M |
| Current Assets | 707.96M |
| Property, Plant & Equipment Net | 66.90M |
| Total Assets | 816.27M |
| Current Liabilities | 106.57M |
| Total Liabilities | 162.52M |
| Accumulated Retained Earnings (Deficit) | -1.85B |
| Accumulated Other Comprehensive Income | -50.00K |
| Shareholders Equity | 653.75M |
| Shareholders Equity (USD) | 653.75M |
| Assets Non-Current | 108.31M |
| Deferred Revenue | 36.42M |
| Goodwill and Intangible Assets | 625.00K |
| Liabilities Non-Current | 55.95M |
| Trade and Non-Trade Payables | 5.51M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.46M |
| Net Cash Flow from Financing | 7.86M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -22.65M |
| Capital Expenditure | -323.00K |
| Issuance (Purchase) of Equity Shares | 7.86M |
| Net Cash Flow from Investing | 23.93M |
| Net Cash Flow - Investment Acquisitions and Disposals | 24.25M |
| Net Cash Flow from Operations | -54.44M |
| Share Based Compensation | 54.19M |